Arboix A. Arterial hypertension, cerebrovascular diseases and dementia. World J Hypertens 2011; 1(1): 7-9
Corresponding Author of This Article
Adrià Arboix, MD, PhD, Associate Professor of Neurology, University of Barcelona, Head of Cerebrovascular Division, Department of Neurology, Capio Hospital Universitari del Sagrat Cor, Viladomat 288, E-08029 Barcelona, Catalonia, Spain. email@example.com
Article-Type of This Article
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Hypertens. Dec 23, 2011; 1(1): 7-9 Published online Dec 23, 2011. doi: 10.5494/wjh.v1.i1.7
Arterial hypertension, cerebrovascular diseases and dementia
Adrià Arboix, Cerebrovascular Division, Department of Neurology, Capio Hospital Universitari del Sagrat Cor, Universitat de Barcelona, E-08029 Barcelona, Catalonia, Spain
ORCID number: $[AuthorORCIDs]
Author contributions: Arboix A solely contributed to this paper.
Correspondence to: Adrià Arboix, MD, PhD, Associate Professor of Neurology, University of Barcelona, Head of Cerebrovascular Division, Department of Neurology, Capio Hospital Universitari del Sagrat Cor, Viladomat 288, E-08029 Barcelona, Catalonia, Spain. firstname.lastname@example.org
Telephone: +34-93-4948940 Fax: +34-93-4948906
Received: April 12, 2011 Revised: October 18, 2011 Accepted: December 16, 2011 Published online: December 23, 2011
Arterial hypertension (AH) is the most relevant risk factor for acute cerebrovascular disease in general. However, the prevalence of AH is not the same for the different stroke subtypes and is particularly high in lacunar infarcts and atherothrombotic stroke, low in infarcts of unusual cause and undetermined origin, and intermediate in cardioembolic stroke. This risk factor has also been related to vascular dementia and Alzheimer’s disease and their pathological manifestations (senile plaques, neurofibrillary tangles, hippocampal atrophy). The mechanisms linking AH to Alzheimer’s disease remain to be elucidated but some recent studies showed that white matter lesions seen on cerebral magnetic resonance imaging appear to be a good marker of this association. Hypertension-associated pathological changes in the brain and its vasculature include vascular remodelling and impaired cerebral autoregulation like hypoperfusion, ischemia and hypoxia, which may initiate the pathological process of Alzheimer’s disease and the expression of dementia. Therefore, prompt diagnosis and adequate control of hypertension and different vascular risk factors are the rational basis for a more effective strategy in the secondary prevention of cerebrovascular disease and dementia.
Stroke after heart disease and cancer is the third commonest cause of death in industrialized countries and accounts for more than 50% of all neurological hospital admissions to adult wards. Hypertension was found in 52% of patients with ischemic stroke included in The Sagrat Cor Hospital of Barcelona Stroke registry and constituted, as in other stroke registries, the most relevant risk factor for acute cerebrovascular disease in general as well as when acute cerebrovascular events are divided into ischemic stroke and hemorrhagic stroke.
HYPERTENSION IN DIFFERENT STROKE SUBTYPES
Although hypertension is extensively recognised as a major cardiovascular risk factor, the prevalence of hypertension is not the same for the different stroke subtypes[1-3]. In our experience, the prevalence of hypertension is particularly high in lacunar infarcts (71.6%) and atherothrombotic stroke (66.1%), low in infarcts of unusual cause (27.2%) and undetermined origin (18.2%), and intermediate in cardioembolic stroke (49.4%) (Table 1). In the Athens Stroke registry, the most frequent risk factors in atherothrombotic stroke were hypertension (73%), smoking (51%) and dyslipidemia (46%), whereas in the Ege Stroke registry, hypertension (70%), diabetes mellitus (45%) and dyslipidemia (35%) were the most common. These findings reveal that hypertension does not constitute the main risk factor for all ischemic stroke subtypes. Hypertension is simultaneously a risk factor (for atherosclerosis) and a cause of lipohyalinosis associated with lacunar infarct (Figure 1).
Table 1 Arterial hypertension and other cardiovascular risk factors according to the ischemic stroke subtype in the Sagrat Cor Hospital of Barcelona Stroke Registry n (%).
Figure 1 Lacunar infarcts (arrows) in semi oval centre (A, B, D, F), thalamus (C) and putamen (E).
Figure provided courtesy of Isidre Ferrer (University of Barcelona, Catalonia, Spain).
On the other hand, high blood pressure may aggravate atherosclerosis and induce complex pathological changes in arteries and arterioles. As a consequence, hypertension is a precursor of large-artery disease and hypertensive small-vessel disease, such as lipohyalinosis, which is one of the most common causes of lacunar infarction[1,6-8]. In a recent clinical study, hypertensive patients with ischemic stroke have different clinical features than non-hypertensive patients. Lacunar syndrome, female gender and previous cerebral infarction were independent variables associated with hypertensive ischemic stroke.
HYPERTENSION IN DEMENTIA
Hypertension is also a risk factor for ischemic white matter lesions, microbleeds, general atherosclerosis, myocardial infarction and cardiovascular diseases, and often clusters with other vascular risk factors, including diabetes mellitus, obesity and hypercholesterolemia. These risk factors have also been related to Alzheimer’s disease and their pathological manifestations (senile plaques, neurofibrillary tangles, hippocampal atrophy). The mechanisms linking hypertension to Alzheimer’s disease remain to be elucidated but some recent studies showed that white matter lesions seen on cerebral magnetic resonance imaging appear to be a good marker of this association. In terms of the pathophysiology of hypertensive brain damage, several hypothesis have been developed, such as hypertension may promote a pre-existing subclinical Alzheimer’s disease, hypertension could determine neurobiological alterations (such as β-amyloid accumulation) resulting in neuropathological damage and, finally, age and cerebrovascular risk factors may act together to cause cerebral vascular degeneration, mitochondrial disruption, reduced glucose oxidation and reduced ATP synthesis. The consequences of these alterations are neuronal death and dementia[10-12]. Hypertension-associated pathological changes in the brain and its vasculature include vascular remodelling and impaired cerebral autoregulation like hypoperfusion, ischemia and hypoxia, which may initiate the pathological process of Alzheimer’s disease and the expression of dementia.
Management of hypertension is equally effective in reducing the risk of stroke in women and men. In addition, recurrent stroke has been shown to be more frequent among hypertensive patients than among non-hypertensive patients[13-16]. Therefore, prompt diagnosis and adequate control of hypertension and different vascular risk factors are the rational basis for a more effective strategy in the secondary prevention of cerebrovascular disease and dementia.
Peer reviewer: Yang-Xin Chen, MD, Associate Professor, Department of Cardiology of Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou 510120, Guangdong Province, China
S- Editor Wang JL L- Editor Roemmele A E- Editor Zheng XM
Arboix A, Roig H, Rossich R, Martínez EM, García-Eroles L. Differences between hypertensive and non-hypertensive ischemic stroke.Eur J Neurol. 2004;11:687-692.
Jackson C, Sudlow C. Are lacunar strokes really different? A systematic review of differences in risk factor profiles between lacunar and nonlacunar infarcts.Stroke. 2005;36:891-901.
Besson G, Hommel M, Perret J. Risk factors for lacunar infarcts.Cerebrovasc Dis. 2000;10:387-390.
Vemmos KN, Takis CE, Georgilis K, Zakopoulos NA, Lekakis JP, Papamichael CM, Zis VP, Stamatelopoulos S. The Athens stroke registry: results of a five-year hospital-based study.Cerebrovasc Dis. 2000;10:133-141.
Kumral E, Ozkaya B, Sagduyu A, Sirin H, Vardarli E, Pehlivan M. The Ege Stroke Registry: a hospital-based study in the Aegean region, Izmir, Turkey. Analysis of 2,000 stroke patients.Cerebrovasc Dis. 1998;8:278-288.
Arboix A, García-Eroles L, Comes E, Oliveres M, Targa C, Balcells M, Pujadas R, Massons J. Importance of cardiovascular risk profile for in-hospital mortality due to cerebral infarction.Rev Esp Cardiol. 2008;61:1020-1029.
Roquer J, Rodríguez-Campello A, Cuadrado-Godia E, Vivanco-Hidalgo RM, Jiménez-Conde J, Perich X, Ois A. Acute brain MRI-DWI patterns and stroke recurrence after mild-moderate stroke.J Neurol. 2010;257:947-953.
Benavente O, White CL, Roldan AM. Small vessel strokes.Curr Cardiol Rep. 2005;7:23-28.
Skoog I, Gustafson D. Update on hypertension and Alzheimer's disease.Neurol Res. 2006;28:605-611.
Tzourio C. Hypertension, cognitive decline, and dementia: an epidemiological perspective.Dialogues Clin Neurosci. 2007;9:61-70.
Grau-Slevin M, Arboix A, Gaffney J, Slevin M. The role of small vessel disease in development of Alzheimer's disease.Neural Regen Res. 2010;5:310-320.
Arboix A, Font A, Garro C, García-Eroles L, Comes E, Massons J. Recurrent lacunar infarction following a previous lacunar stroke: a clinical study of 122 patients.J Neurol Neurosurg Psychiatry. 2007;78:1392-1394.
Arboix A, Massons J, García-Eroles L, Comes E, Balcells M, Oliveres M. [Recurrent ischemic stroke. Study of 605 patients].Med Clin (Barc). 2011;137:541-545.
Hillen T, Coshall C, Tilling K, Rudd AG, McGovern R, Wolfe CD. Cause of stroke recurrence is multifactorial: patterns, risk factors, and outcomes of stroke recurrence in the South London Stroke Register.Stroke. 2003;34:1457-1463.
Cerebrovascular diseases; Catalan Society of Neurology. Official Guidelines for diagnosis and treatment.2nd ed. Barcelona: Societat Catalana de Neurologia 2011; 52-54.